欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2009, Vol. 14 ›› Issue (9): 995-999.

• 药代会专栏 • 上一篇    下一篇

两性霉素B 脂质体药代动力学及组织分布研究

徐智儒1, 秦燕1, 毛文学2, 刘全海1   

  1. 1上海医药工业研究院药理室, 上海200437;
    2上海复旦张江生物医药股份有限公司, 上海201210
  • 收稿日期:2009-08-31 修回日期:2009-09-28 发布日期:2020-11-03
  • 通讯作者: 刘全海, 男, 研究员, 博导, 研究方向:分子药理学, 肿瘤药理。Tel:021-55514600-333 13761629745 E-mail: liuquanhailqh@163.com
  • 作者简介:徐智儒, 女, 硕士, 助理研究员, 研究方向:药代动力学和药物分析。Tel:021-55514600-341 13761629745 E-mail: zhiruxu@hotmail.com

Pharmacokinetics and distribution of amphotericin B liposome in animals

XU Zhi-ru1, QIN Yan1, MAO Wen-xue2, LIU Quan-hai1   

  1. 1Shanghai Institute of Pharmaceutical Industry, Shanghai 200437, China;
    2Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., Shanghai 201210, China
  • Received:2009-08-31 Revised:2009-09-28 Published:2020-11-03

摘要: 目的: 测定血浆及组织中两性霉素B 的浓度, 并比较受试与参比两性霉素B 脂质体在犬体内药代动力学性质及大鼠主要组织分布特性。方法: 6 只犬静脉随机、交叉给予受试及参比药物,剂量为5 mg/kg, 在不同时间点采集血浆样品;大鼠同样剂量静脉给予受试及参比药物, 在给药后不同时间点取组织样品。用HPLC 法测定生物样品中两性霉素B 浓度, 并用DAS 2.0 软件拟合求算药代动力学参数。结果: 犬i. v. 给药两性霉素B 脂质体后血药浓度-时间曲线符合二室模型, 主要药代动力学参数为, 受试药物:t1/2β (53.6±2.2)h, AUC (18.7±3.2)mg·L-1·h, CL(0.23±0.05)L·h-1·kg-1, V1 (11.6±2.8)L/kg ;参比药物: t1/2β (52.8± 0.9)h, AUC (19.6±2.2)mg·L-1 ·h, CL(0.22±0.03)L·h-1 ·kg-1, V1(10.6±2.9)L/kg 。结论: 对上述参数以SAS 统计软件进行双侧t 检验, 结果表明给予受试及参比药物后犬主要药代动力学参数差异无统计学意义(P >0.05)。对各时间点主要脏器的药物浓度进行比较, 差异无统计学意义(P >0.05)。

关键词: 两性霉素B, 脂质体, HPLC, 药代动力学

Abstract: AIM: To determine amphotericin B concentrations in plasma and tissues and to compare the pharmacokinetic profile in dogs and distribution profile in SD rats main tissues of test and reference amphotericin B liposome. METHODS: Six dogs were intravenously administered of 5 mg/kg test and reference preparations in an randomized cross-over study. Blood samples were collected at various time-points after drug administration. Rats were intravenously administered of 5 mg/kg test and reference preparations, tissues were collected at various time-points after drug administration. Analytical method based on HPLC method was established to determine the plasma and tissue concentration. The pharmacokinetic evaluation was carried out using the DAS 2.0 program. RESULTS: Six dogs were intravenously administered of 5 mg/kg amphotericin B liposome, and an open two compartment model best described the concentration-time profiles for amphotericin B liposome. The main pharmacokinetic parameters were t1/2β(53.6±2.2)h, AUC(18.7±3.2)mg·L-1·h ; CL(0.23±0.05) L·h-1 ·kg-1, V1 (11.6±2.8) L/kg for the test preparation and t1/2β(52.8±0.9)h, AUC(19.6±2.2)mg·L-1·h, CL (0.22±0.03) L·h-1 ·kg-1, V1(10.6±2.9)L/kg for the reference preparation. CONCLUSION: The statistics analysis shows that there are no significant differences(P > 0.05)between the test and reference preparation in major pharmacokinetic parameters in dogs and tissue distribution in rats.

Key words: amphotericin B, liposome, HPLC, pharmacokinetics

中图分类号: